News from integral molecular A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 05, 2021, 07:45 ET Integral Molecular Enables Rapid Resistance Testing of Vaccines and Drugs Against Emerging Coronavirus Variants

In response to the evolving COVID-19 pandemic, Integral Molecular has adapted its SARS-CoV-2 reporter virus particle (RVP) technology to reflect...

Jan 07, 2021, 15:00 ET Integral Molecular and Optimeos Partner to Deliver Long-acting Therapeutic Antibodies Using Nanoparticle Formulation Technology

Integral Molecular and Optimeos Life Sciences have partnered to develop antibody therapeutics using long-acting, sustained delivery formulations that ...

Oct 14, 2020, 08:00 ET Totient Leverages Integral Molecular's Membrane Proteome Array to Advance Cancer Therapeutic Discovery

Integral Molecular and Totient announce a partnership leveraging Integral Molecular's Membrane Proteome Array (MPA) target identification technology...

Sep 21, 2020, 07:00 ET Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania to Advance COVID-19 Research

Integral Molecular has been awarded $521,723 from the Commonwealth of Pennsylvania to leverage its technologies in the global fight against COVID-19. ...

Sep 10, 2020, 12:37 ET Humanized Chicken Antibody Technology to Drive Next Generation of Integral Molecular's MPS Antibody Discovery Platform

Integral Molecular announces the development of Humanized Chicken Antibody Technology (hCAT) and the incorporation of hCAT into the company's...

Jul 14, 2020, 12:21 ET Integral Molecular Expands its Reporter Virus Technology to Enable Broad Testing for Coronavirus Protection Against Emerging Strains Including D614G

Integral Molecular has launched an expanded panel of SARS-CoV-2 Reporter Virus Particles (RVP), which includes spike protein variants such as D614G...

Jun 12, 2020, 10:31 ET Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology

Integral Molecular, the leader in discovering and characterizing antibodies against membrane protein and viral targets, is applying its Membrane...

Apr 30, 2020, 11:50 ET Integral Molecular Develops Test for Neutralizing Antibodies in COVID-19 Patients and Clinical Trials

Integral Molecular announces the launch of SARS-CoV-2 Reporter Virus Particles (RVPs) to test patients for the presence of neutralizing antibodies,...

Mar 09, 2020, 10:47 ET Integral Molecular Accelerates Coronavirus Vaccine Research

Integral Molecular announces the mobilization of two of its key technology platforms to aid in the discovery of vaccines and therapeutics against the ...

Feb 13, 2020, 10:30 ET Integral Molecular Launches ReadyMap Services for Rapid, Conformational Epitope Mapping

Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces the launch of...

Jan 09, 2020, 11:00 ET Integral Molecular Announces Preclinical P2X7 Antibody Assets for Autoimmune Disorders

Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces lead monoclonal antibodies (MAbs) against...

Nov 14, 2019, 08:00 ET Integral Molecular to Advance Vaccine Discovery with NIH Contract for $5.5M

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular a contract (75N93019C00073) which will provide up to ...

Oct 18, 2019, 08:00 ET Philadelphia's Integral Molecular Opens New Research Center in Response to Upsurge in Antibody Discovery Partnerships

Integral Molecular, the industry leader in membrane protein solutions, has expanded its research facility to a second location to accommodate an...

Sep 26, 2019, 14:00 ET Integral Molecular Selected as the First Industry Partner in The Wistar Institute's Biomedical Research Technician Apprenticeship

Integral Molecular, Inc. has been selected by The Wistar Institute, a global leader in cancer, immunology and infectious disease research as the...

May 28, 2019, 10:12 ET Integral Molecular Reaches Milestone in Immuno-Oncology Target Discovery Collaboration with Daiichi Sankyo

Integral Molecular, the industry leader in discovering antibodies against multipass membrane proteins, today announced that it has successfully...

Apr 16, 2019, 09:12 ET Integral Molecular Doubles Antibody Characterization Capacity Within Philadelphia's Science Center

Integral Molecular, the industry leader in membrane protein solutions, today announced the expansion of its two proprietary antibody characterization ...